A study of Myb34.5 for the treatment of pancreatic cancer.
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Oncolytic viruses (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; First in man
- 28 Jul 2016 New trial record
- 25 Jul 2016 According to a Karcinolys media release, the company expects to initiate this trial at the end of second half of 2016.